The development of gepotidacin was funded by the pharmaceutical company GSK, which is responsible for manufacturing the new ...

the plaque assay methods have been adapted to other intracellular bacterial pathogens. There is no single model, thus each assay should be refined depending on the bacteria studied and the purpose ...

1Laboratory of Signaling and Gene Regulation, Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas, Texas. 2Section of Laboratory ...

The immune system is a complex network of various cellular components that must differentiate between pathogenic bacteria and the commensal bacteria of the human ... and washed 2 × 100 μl in ...

Antibiotics treat or prevent infections by killing bacteria or slowing down their growth. A large proportion of these drugs do this by disrupting an essential piece of cellular machinery called the ...

This study aimed to investigate the activity of colistin in combination with the anti-rheumatic drug auranofin against Col-R Gram-negative bacteria. The results of checkerboard analysis demonstrated ...

The hydrothermal vent tubeworm Riftia pachyptila hosts a single 16S rRNA phylotype of intracellular sulfur-oxidizing symbionts ... biosynthetic pathways to be regulated less stringently (compared to ...

When a bacterium enters a cell’s cytoplasm, intracellular lipid droplets close in, bringing with them an arsenal of antimicrobial proteins, the research shows. “This is the first evidence that there’s ...